Translating the molecular diversity of hepatocellular carcinoma into clinical practice
Abstract
Deciphering genomic diversity could improve clinical care for patients with hepatocellular carcinoma. Recently, our study group identified 161 putative driver genes and 2 new mutational signatures, and demonstrated that 28% of patients harbor targetable alterations. This could be the first promising step in the development of genome-based clinical trials.
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 2372-3556 |
| DOIs | |
| Publication status | Published - 07.2016 |
| Externally published | Yes |
| PubMed | 27652310 |
|---|
